Although Src proteins behave as oncogenes, Blk was shown to act as a tumor suppressor through the regulation of CML cells proliferation, in a pathway involving c-myc and p27 (Fig. 3). The gene discussed is BLK; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.